Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2025-12-24 @ 11:13 PM
NCT ID:
NCT01436669
Eligibility Criteria:
Inclusion Criteria:
1. Male or female, age \> 18.
2. Able to give informed written consent in the English language.
3. Diagnosis of cancer and receiving chemotherapy or with a planned chemotherapy start date within 2 weeks of enrolment.
4. Patients who are able to perform finger prick test to obtain capillary blood.
Exclusion Criteria:
1. Inability to give informed consent due to mental capacity or language problems.
2. Patients at risk of bruising or bleeding as a result of their disease or treatment.
3. Patients at risk of bruising or bleeding due to anticoagulants (heparin or warfarin), aspirin or thrombocytopenia (platelet count \<80).
4. Patients with diabetes mellitus
5. Patients with peripheral neuropathy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
75 Years
Study:
NCT01436669
Study Brief:
Protocol Section:
NCT01436669